UAE-based Julphar Gulf Pharmaceutical Industries has opened its first manufacturing facility in the Gerji Jakros region of Addis Ababa, Ethiopia.
Julphar said it has invested ETB170m ($9.13m) in constructing new facility, which was built in conjunction with its local Ethiopian partner, Medtech, and occupies 40,000 ft² space.
The plant, which is a cGMP compliant, is designed and built by Julphar’s engineering and construction division, and is working towards international accreditation.
The facility, once fully operational, will produce 25 million bottles of suspension and syrup, 500 million tablets and 200 million capsules annualy.
The new plant products will serve not only the local market but also the African continent.
Medtech CEO Dr Mohamed Nuri said the firm is happy to take part to provide medicines throughout Africa.
"The opening of this facility will enable us not only to be a vital supplier to the local market but way beyond across the whole continent," Nuri added.
"We have worked in alignment with the Ethiopian government and other global health organizations in the planning of this facility and we are excited about the impact this will have on local healthcare."